Pathology
Main Filters
Pathology
| AGILENT TECHNOLOGIES, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| G110844G | 0 | - | ||
| G110845G | 0 | - | ||
| G110846G | 0 | - | ||
| G110847G | 0 | - | ||
| G110848G | 0 | - | ||
| G110849G | 0 | - | ||
| G110850G | 0 | - | ||
| G110851G | 0 | - | ||
| G110852G | 0 | - | ||
| G110853G | 0 | - | ||
| G110854G | 0 | - | ||
| G110855G | 0 | - | ||
| G110856G | 0 | - | ||
| G110857G | 0 | - | ||
| G110859G | 0 | - | ||
| G110860G | 0 | - | ||
| G110861G | 0 | - | ||
| G110876G | 0 | - | ||
| G110877G | 0 | - | ||
| G110882G | 0 | - | ||
| G110885G | 0 | - | ||
| G110892G | 0 | - | ||
| G110895G | 0 | - | ||
| G110896G | 0 | - | ||
| G110898G | 0 | - | ||
| LFXBIO | 0 | - | ||
| LFXW-SI | 0 | - | ||
| LLXW-SI | 0 | - | ||
| Ambu A/S | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 480300000 | 0 | - | ||
| 480500000US | 0 | - | ||
| Cedarlane Corporation | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 90-0005 | 0 | - | ||
| 90-0009 | 0 | - | ||
| 90-0020 | 0 | - | ||
| 90-0021 | 0 | - | ||
| 90-0038 | 0 | - | ||
| FL1 | 0 | - | ||
| FL1S | 0 | - | ||
| FL2 | 0 | - | ||
| FL2S | 0 | - | ||
| Immudex ApS | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| NI03233A PE 50 | 0 | - | ||
| WA02131A PE 50 | 0 | - | ||
| WB02132A PE 50 | 0 | - | ||
| WC02197A PE 50 | 0 | - | ||
| WF02133A PE 50 | 0 | - | ||
| WH02135A PE 50 | 0 | - | ||
| WH02136A PE 50 | 0 | - | ||
| WI02137A PE 50 | 0 | - | ||
| WK02138A PE 50 | 0 | - | ||
| Ssi Diagnostica A/S | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 3459 | 0 | - | ||
| 68866 | 0 | - | ||
18,175 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
CMV Dextramer
Immudex ApS
Analyte specific reagent. Analytical and performance characteristics are not established.Negative Dextramers comprise dextran polymer backbone carrying multiple fluorochrome molecules (PE) and multiple MHC I-peptide complexes displaying nonsense peptide.Negative Dextramers are not reactive with T cell receptors of normal human CD8+ T cells.The reagent is provided in liquid form in volumes of 0,5 ml in buffer containing 1% bovine serum albumin (BSA) and 15 mmol/L NaN, pH 7.2.
0
-
CMV Dextramer
Immudex ApS
Analyte specific reagent. Analytical and performance characteristics are not established.CMV Dextramer reagents react with T cell receptors on human CD8+ T cells restricted by the HLA allele of the Dextramer and specific for the CMV peptide displayed.CMV Dextramers comprise dextran polymer backbone carrying multiple fluorochrome molecules (PE) and multiple MHC-peptide complexes displaying a peptide epitope from a CMV antigen. CMV Dextramer reagents are provided in liquid form in volumes of 0,5 ml in buffer containing 1% bovine serum albumin (BSA) and 15 mmol/L NaN, pH 7.2.
0
-
CMV Dextramer
Immudex ApS
Analyte specific reagent. Analytical and performance characteristics are not established.CMV Dextramer reagents react with T cell receptors on human CD8+ T cells restricted by the HLA allele of the Dextramer and specific for the CMV peptide displayed.CMV Dextramers comprise dextran polymer backbone carrying multiple fluorochrome molecules (PE) and multiple MHC-peptide complexes displaying a peptide epitope from a CMV antigen. CMV Dextramer reagents are provided in liquid form in volumes of 0,5 ml in buffer containing 1% bovine serum albumin (BSA) and 15 mmol/L NaN, pH 7.2.
0
-
CMV Dextramer
Immudex ApS
Analyte specific reagent. Analytical and performance characteristics are not established.CMV Dextramer reagents react with T cell receptors on human CD8+ T cells restricted by the HLA allele of the Dextramer and specific for the CMV peptide displayed.CMV Dextramers comprise dextran polymer backbone carrying multiple fluorochrome molecules (PE) and multiple MHC-peptide complexes displaying a peptide epitope from a CMV antigen. CMV Dextramer reagents are provided in liquid form in volumes of 0,5 ml in buffer containing 1% bovine serum albumin (BSA) and 15 mmol/L NaN, pH 7.2.
0
-
CMV Dextramer
Immudex ApS
Analyte specific reagent. Analytical and performance characteristics are not established.CMV Dextramer reagents react with T cell receptors on human CD8+ T cells restricted by the HLA allele of the Dextramer and specific for the CMV peptide displayed.CMV Dextramers comprise dextran polymer backbone carrying multiple fluorochrome molecules (PE) and multiple MHC-peptide complexes displaying a peptide epitope from a CMV antigen. CMV Dextramer reagents are provided in liquid form in volumes of 0,5 ml in buffer containing 1% bovine serum albumin (BSA) and 15 mmol/L NaN, pH 7.2.
0
-
CMV Dextramer
Immudex ApS
Analyte specific reagent. Analytical and performance characteristics are not established.CMV Dextramer reagents react with T cell receptors on human CD8+ T cells restricted by the HLA allele of the Dextramer and specific for the CMV peptide displayed.CMV Dextramers comprise dextran polymer backbone carrying multiple fluorochrome molecules (PE) and multiple MHC-peptide complexes displaying a peptide epitope from a CMV antigen. CMV Dextramer reagents are provided in liquid form in volumes of 0,5 ml in buffer containing 1% bovine serum albumin (BSA) and 15 mmol/L NaN, pH 7.2.
0
-
CMV Dextramer
Immudex ApS
Analyte specific reagent. Analytical and performance characteristics are not established.CMV Dextramer reagents react with T cell receptors on human CD8+ T cells restricted by the HLA allele of the Dextramer and specific for the CMV peptide displayed.CMV Dextramers comprise dextran polymer backbone carrying multiple fluorochrome molecules (PE) and multiple MHC-peptide complexes displaying a peptide epitope from a CMV antigen. CMV Dextramer reagents are provided in liquid form in volumes of 0,5 ml in buffer containing 1% bovine serum albumin (BSA) and 15 mmol/L NaN, pH 7.2.
0
-
CMV Dextramer
Immudex ApS
Analyte specific reagent. Analytical and performance characteristics are not established.CMV Dextramer reagents react with T cell receptors on human CD8+ T cells restricted by the HLA allele of the Dextramer and specific for the CMV peptide displayed.CMV Dextramers comprise dextran polymer backbone carrying multiple fluorochrome molecules (PE) and multiple MHC-peptide complexes displaying a peptide epitope from a CMV antigen. CMV Dextramer reagents are provided in liquid form in volumes of 0,5 ml in buffer containing 1% bovine serum albumin (BSA) and 15 mmol/L NaN, pH 7.2.
0
-
CMV Dextramer
Immudex ApS
Analyte specific reagent. Analytical and performance characteristics are not established.CMV Dextramer reagents react with T cell receptors on human CD8+ T cells restricted by the HLA allele of the Dextramer and specific for the CMV peptide displayed.CMV Dextramers comprise dextran polymer backbone carrying multiple fluorochrome molecules (PE) and multiple MHC-peptide complexes displaying a peptide epitope from a CMV antigen.CMV Dextramer reagents are provided in liquid form in volumes of 0,5 ml in buffer containing 1% bovine serum albumin (BSA) and 15 mmol/L NaN, pH 7.2.
0
-
aScope BronchoSamplerâ„¢ SC
Ambu A/S
Ambu aScope BronchSampler container. Single-use and sterile. Volume of container: 30 ml Minimum purchase is 10 pcs. = 1 box
0
-
SureFISH 9p24.3 Chr9pTel 428kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 9p24.3 Chr9pTel 428kb P20 GR
0
-
SureFISH 8p23.3 Chr8pTel 406kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 8p23.3 Chr8pTel 406kb P20 GR
0
-
SureFISH 7p22.3 Chr7pTel 426kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 7p22.3 Chr7pTel 426kb P20 GR
0
-
SureFISH 5q35.3 Chr5qTel 397kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 5q35.3 Chr5qTel 397kb P20 GR
0
-
SureFISH 2q37.3 Chr2qTel 415kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 2q37.3 Chr2qTel 415kb P20 GR
0
-
SureFISH 1p36.33 Chr1pTel 417kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 1p36.33 Chr1pTel 417kb P20 GR
0
-
SureFISH 16q24.3 Chr16qTel 424kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 16q24.3 Chr16qTel 424kb P20 GR
0
-
SureFISH 16p13.3 Chr16pTel 428kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 16p13.3 Chr16pTel 428kb P20 GR
0
-
SureFISH 9q34.3 Chr9qTel 429kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 9q34.3 Chr9qTel 429kb P20 GR
0
-
SureFISH 3p26.3 Chr3pTel 381kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 3p26.3 Chr3pTel 381kb P20 GR
0
-
SureFISH 2p25.3 Chr2pTel 391kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 2p25.3 Chr2pTel 391kb P20 GR
0
-
SureFISH 10q26.3 Chr10qTel 391kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 10q26.3 Chr10qTel 391kb P20 GR
0
-
SureFISH 10p15.3 Chr10pTel 372kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 10p15.3 Chr10pTel 372kb P20 GR
0
-
SureFISH 15q26.3 Chr15qTel 391kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 15q26.3 Chr15qTel 391kb P20 GR
0
-
SureFISH 7q36.3 Ch7qTel 396kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 7q36.3 Ch7qTel 396kb P20 GR
0
-
SureFISH 3q29 Chr3qTel 380kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 3q29 Chr3qTel 380kb P20 GR
0
-
SureFISH 1q44 Chr1qTel 402kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 1q44 Chr1qTel 402kb P20 GR
0
-
SureFISH 14q32.33 Chr14qTel 415kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 14q32.33 Chr14qTel 415kb P20 GR
0
-
SureFISH 22q13.33 Chr22qTel 383kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 22q13.33 Chr22qTel 383kb P20 GR
0
-
SureFISH 20q13.33 Chr20qTel 379kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 20q13.33 Chr20qTel 379kb P20 GR
0
-
SureFISH 20p13 Chr20pTel 386kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 20p13 Chr20pTel 386kb P20 GR
0
-
SureFISH 19q13.43 Chr19qTel 405kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 19q13.43 Chr19qTel 405kb P20 GR
0
-
SureFISH 19p13.3 Chr19pTel 409kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 19p13.3 Chr19pTel 409kb P20 GR
0
-
SureFISH 18q23 Chr18qTel 413kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 18q23 Chr18qTel 413kb P20 GR
0
-
SureFISH 18p11.32 Chr18pTel 403kb P20 GR
AGILENT TECHNOLOGIES, INC.
SureFISH 18p11.32 Chr18pTel 403kb P20 GR
